Bmi-1 Promotes Glioma Angiogenesis by Activating NF-κB Signaling
暂无分享,去创建一个
Xun Zhu | Bo Hu | Shi-Yuan Cheng | Libing Song | Jueheng Wu | Mengfeng Li | Bo Hu | Shi-Yuan Cheng | Lili Jiang | Libing Song | Xun Zhu | Yi Yang | Lili Jiang | Jueheng Wu | Mengfeng Li | Yi Yang
[1] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[2] Eric C. Holland,et al. Gliomagenesis: genetic alterations and mouse models , 2001, Nature Reviews Genetics.
[3] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[4] Yi Jiang,et al. A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. , 2007, Biophysical journal.
[5] Napoleone Ferrara,et al. VEGF and the quest for tumour angiogenesis factors , 2002, Nature Reviews Cancer.
[6] Byung Hak Kim,et al. Inhibitory action of novel aromatic diamine compound on lipopolysaccharide‐induced nuclear translocation of NF‐κB without affecting IκB degradation , 2004 .
[7] A. Bikfalvi,et al. Structure and Inhibitory Effects on Angiogenesis and Tumor Development of a New Vascular Endothelial Growth Inhibitor* , 2003, Journal of Biological Chemistry.
[8] L. Parada,et al. The Molecular and Genetic Basis of Neurological Tumours , 2002, Nature Reviews Cancer.
[9] Peter Carmeliet,et al. Angiogenesis in life, disease and medicine , 2005, Nature.
[10] M. Ohtaki,et al. Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia , 2007, Leukemia.
[11] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[12] Libing Song,et al. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer , 2011, Molecular Cancer.
[13] Y. Katayama,et al. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel–Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein , 2005, Medical Molecular Morphology.
[14] Xinyu Zhao,et al. shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis. , 2012, Lung cancer.
[15] Jun Li,et al. Biomarkers , Genomics , Proteomics , and Gene Regulation miR-182 as a Prognostic Marker for Glioma Progression and Patient Survival , 2010 .
[16] R. DePinho,et al. Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.
[17] A. Bhushan,et al. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. , 2009, Genes & development.
[18] L. Taylor. Diagnosis, treatment, and prognosis of glioma , 2010, Neurology.
[19] Libing Song,et al. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. , 2010, The American journal of pathology.
[20] Byung Hak Kim,et al. Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. , 2004, FEBS letters.
[21] Xin Chen,et al. Bmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic Carcinogenesis , 2009, Molecular Cancer Research.
[22] Libing Song,et al. Bmi-1, stem cells and cancer. , 2009, Acta biochimica et biophysica Sinica.
[23] M. Lindström,et al. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53 , 2001, Oncogene.
[24] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[25] Mitchel S Berger,et al. Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.
[26] Hua-mei Tang,et al. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer , 2010, Journal of Cancer Research and Clinical Oncology.
[27] B. Aggarwal,et al. A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NFκB motif drives the transition from a repressed to an activated state of gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] A. Palotie,et al. Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C* , 1997, The Journal of Biological Chemistry.
[29] P. Salvén,et al. Angiogenic and Lymphangiogenic Molecules in Hematological Malignancies , 2002, Leukemia & lymphoma.
[30] Carlo Sala,et al. Antiangiogenic Therapy for Glioma , 2012, Journal of signal transduction.
[31] D. Ribatti,et al. The role of microenvironment in tumor angiogenesis , 2008, Genes & Nutrition.
[32] M. Lohuizen,et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression , 2001, British Journal of Cancer.
[33] Anton Berns,et al. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.
[34] Jun Li,et al. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. , 2012, The Journal of clinical investigation.
[35] C. Shun,et al. Induced interleukin-8 expression in gliomas by tumor-associated macrophages , 2009, Journal of Neuro-Oncology.
[36] G. Dontu,et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.
[37] Wenlin Huang,et al. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. , 2009, The Journal of clinical investigation.
[38] Susan M. Chang,et al. Recent advances in therapy for glioblastoma. , 2010, Archives of neurology.
[39] R. DePinho,et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus , 1999, Nature.
[40] Erwin G. Van Meir,et al. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. , 2005, Neuro-oncology.
[41] P. Black,et al. Microvessel density is a prognostic indicator for patients with astroglial brain tumors , 1996, Cancer.
[42] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[43] L. Sui,et al. Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer , 2008, British journal of biomedical science.
[44] Yun-Fei Xia,et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. , 2006, Cancer research.
[45] B. Birlik,et al. Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas , 2006, Neuropathology and applied neurobiology.